118 related articles for article (PubMed ID: 14559987)
1. Expression of HER2 and C-KIT in nasopharyngeal carcinoma: implications for a new therapeutic approach.
Bar-Sela G; Kuten A; Ben-Eliezer S; Gov-Ari E; Ben-Izhak O
Mod Pathol; 2003 Oct; 16(10):1035-40. PubMed ID: 14559987
[TBL] [Abstract][Full Text] [Related]
2. Pediatric nasopharyngeal carcinoma: better prognosis and increased c-Kit expression as compared to adults.
Bar-Sela G; Ben Arush MW; Sabo E; Kuten A; Minkov I; Ben-Izhak O
Pediatr Blood Cancer; 2005 Sep; 45(3):291-7. PubMed ID: 15558705
[TBL] [Abstract][Full Text] [Related]
3. P53 overexpression in nasopharyngeal carcinoma.
Agaoglu FY; Dizdar Y; Dogan O; Alatli C; Ayan I; Savci N; Tas S; Dalay N; Altun M
In Vivo; 2004; 18(5):555-60. PubMed ID: 15523893
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of Bcl-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histological type and survival.
Vera-Sempere FJ; Burgos JS; Botella MS; Morera C
Histol Histopathol; 1997 Jan; 12(1):9-18. PubMed ID: 9046038
[TBL] [Abstract][Full Text] [Related]
6. [Expression of c-kit in North African nasopharyngeal carcinomas: correlation with age and LMP1].
Charfi S; Khabir A; Ayadi L; Mseddi M; Makni H; Gorbel A; Daoud J; Frikha M; Jlidi R; Busson P; Boudawara TS
Cancer Radiother; 2007 Sep; 11(5):247-51. PubMed ID: 17689127
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
Massard C; Voigt JJ; Laplanche A; Culine S; Lortholary A; Bugat R; Theodore C; Priou F; Kaminsky MC; Lesimple T; Pivot X; Coudert B; Douillard JY; Merrouche Y; Fizazi K
Br J Cancer; 2007 Oct; 97(7):857-61. PubMed ID: 17876336
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
9. Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma.
Mäkitie AA; MacMillan C; Ho J; Shi W; Lee A; O'Sullivan B; Payne D; Pintilie M; Cummings B; Waldron J; Warde P; Irish J; Brown D; Gilbert R; Gullane P; Liu FF; Kamel-Reid S
Clin Cancer Res; 2003 Jun; 9(6):2177-84. PubMed ID: 12796384
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
11. COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL
Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595
[TBL] [Abstract][Full Text] [Related]
12. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
Chen CL; Ou DL
Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.
Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T
Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959
[TBL] [Abstract][Full Text] [Related]
14. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization.
Wang X; MacLennan GT; Zhang S; Montironi R; Lopez-Beltran A; Tan PH; Foster S; Baldridge LA; Cheng L
Hum Pathol; 2009 Feb; 40(2):211-7. PubMed ID: 18799188
[TBL] [Abstract][Full Text] [Related]
15. [Significance of her2 oncogene expression in primary nasopharyngeal carcinoma].
Yan J; Fang Y; Jiao Y
Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):904-6. PubMed ID: 11702662
[TBL] [Abstract][Full Text] [Related]
16. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
17. Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival.
Bar-Sela G; Kaplan-Cohen V; Ilan N; Vlodavsky I; Ben-Izhak O
Histopathology; 2006 Aug; 49(2):188-93. PubMed ID: 16879396
[TBL] [Abstract][Full Text] [Related]
18. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
[TBL] [Abstract][Full Text] [Related]
19. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of Fas-ligand expression in nasopharyngeal carcinoma.
Ho SY; Guo HR; Chen HH; Hsiao JR; Jin YT; Tsai ST
Head Neck; 2004 Nov; 26(11):977-83. PubMed ID: 15390195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
